Vemedia Group sells its pharmaceutical raw materials division ABC-Chemicals
26th November 2013 – Vemedia Group, a leading European OTC producer and distributor, acquired last year by funds advised by IK Investment Partners, will continue to further focus on OTC self-care products.
Vemedia Group has therefore sold its pharmaceutical raw materials division ABC-Chemicals SA, based in Wauthier-Braine (Belgium) to Euphaco.
Euphaco has recently been created by Mario Debel (ex-Omega Pharma), Ludwig Geldof (ex-2Pharma) and Hanne Dewulf (ex-2Pharma) together with the financial support and commitment of Indufin and Damier (Yvan Vindevogel).
Euphaco stands for European Pharmaceutical Compounding, which clearly reflects its intention to play a larger role in the market of raw materials and ingredients used for pharmaceutical compounding in pharmacies, hospitals and others, as demonstrated by this first acquisition. Euphaco intends to develop a broad range of raw materials and various accessories & services for the European market and wants to become a “Total Solution Partner” for its clients.
Euphaco: Mario Debel: email@example.com – GSM +32 479 65 67 43
Vemedia Group: Rob Drenth: firstname.lastname@example.org – Tel +31 20 519 83 00
Indufin: Joris Rome: email@example.com – GSM +32 495 50 17 07
Vemedia Group (www.vemediapharma.com), with home markets in Netherlands, Belgium, France, Spain, Portugal and Italy is a leading and innovative player in OTC (prescription-free) medicines. The group is active in various European countries and also exports its products beyond Europe.
Damier is an international investment vehicle that focuses on a specific number of sectors by actively dedicating funds to companies with activities in the consumer sector (more specifically the consumer health business).
Indufin is (www.indufin.be) is an investment company owned by Luxempart (a listed investment company in Luxembourg) and De Eik (a private investment company in Belgium), focusing on non-quoted companies. Indufin invests in successful medium-sized companies with ambitious growth plans. Indufin develops a strong partnership with its portfolio companies, based on a shared vision of the future and a relationship of trust. The current portfolio comprises 8 investments.Download as pdf